Pelthos Therapeutics 8K Filing
Pelthos Therapeutics files 8K with SEC, disclosing financial statements and exhibits. The filing may contain material information for investors.
Filed: 2026-05-28 AccNo: 0001919246-26-000085 Size: 3 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits